A/Prof Michelle Yong
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
78 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR T Cell Recipients – PART 1: Risk Factors, Clinical Impact and Immune Response
DOI: 10.1002/rmv.701422026
Journal article
Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR-T Cell Recipients—PART 2: Antiviral Therapy and Virus-Specific T Cell Therapy for HCMV in Allo-HSCT
DOI: 10.1002/rmv.701352026
Journal article
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer.
DOI: 10.1097/QCO.00000000000011982026
Journal article
Cytomegalovirus reactivation in multiple myeloma patients receiving bispecific antibodies.
DOI: 10.1182/bloodadvances.20250195632024
Research grants (ARC, NHMRC, MRFF)
Transforming Infection Management in the Era of Emerging Cancer Therapies
2022
Research grants (ARC, NHMRC, MRFF)
Improving Patient Outcomes Through Implementation of Digital and Diagnostic Innovations for Infections in Cancer
2020
Research Grant
ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients
RECENT SCHOLARLY WORKS
2026
Journal article
QuantiFERON-CMV Monitoring Post-Allogeneic Hematopoietic Stem Cell Transplantation Is Dynamic and Predictive of Immediate Cytomegalovirus Outcomes
DOI: 10.1111/tid.701522026
Journal article
Rhino-sino-orbital and/or central nervous system infections due to Lomentospora prolificans and Scedosporium spp. in onco-haematology patients
DOI: 10.1093/mmy/myag0162026
Journal article
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial
DOI: 10.1093/cid/ciaf4092026
Journal article
Infection Prevention and Surveillance in the Care of Australasian Solid-Organ Transplant Recipients
DOI: 10.1111/tid.701492025
Journal article
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial
DOI: 10.1093/infdis/jiaf2972025
Journal article
Antifungal prophylaxis in patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive acute myeloid leukaemia receiving sorafenib during initial induction and consolidation treatment in ALLG AMLM16 trial
DOI: 10.1093/jac/dkaf385
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
ADAPT (Achieving Durable Remission via Adaptive Pro-Survival Targeting in Acute Myeloid Leukaemia)
2026
Research grants (international)
Isavuconazole Treatment and Prophylaxis in Adult and Paediatric Patients With Cancer - A Multicentre National Study (The SHIELD Study)